PSMA After Recurrence, and PSMA Specificity | Answering YouTube Comments #26 | Mark Scholz, MD
PSMA After Recurrence, and PSMA Specificity | Answering YouTube Comments #26 | Mark Scholz, MD
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

PSMA After Recurrence, and PSMA Specificity | Answering YouTube Comments #26 | Mark Scholz, MD

PSMA After Recurrence, and PSMA Specificity | Answering YouTube Comments #26 | Mark Scholz, MD

|
PSMA Needed if Axumin Detects Metastases? | Answering YouTube Comments #30 | Mark Scholz, MD | PCRI

PSMA Needed if Axumin Detects Metastases? | Answering YouTube Comments #30 | Mark Scholz, MD | PCRI

|
How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRI

How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRI

|
PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MD

PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MD

|
Recurrent and Advanced Prostate Cancer | Answering Youtube Comments #5, The PCRI

Recurrent and Advanced Prostate Cancer | Answering Youtube Comments #5, The PCRI

|
Prostate Cancer Assays, OPKO 4K, SelectMDX | Answering YouTube Comments #38 | Mark Scholz, MD | PCRI

Prostate Cancer Assays, OPKO 4K, SelectMDX | Answering YouTube Comments #38 | Mark Scholz, MD | PCRI

|
PSA on Intermittent Hormone Therapy & Testosterone Levels After Eligard | YouTube Comments #27

PSA on Intermittent Hormone Therapy & Testosterone Levels After Eligard | YouTube Comments #27

|
Exercise Routine & Seed Implants with Urinary Symptoms | Answering YouTube Comments #36

Exercise Routine & Seed Implants with Urinary Symptoms | Answering YouTube Comments #36

|
How PSMA Can Change Treatment Decisions for Prostate Cancer | Mark Moyad, MD, MPH & Mark Scholz, MD

How PSMA Can Change Treatment Decisions for Prostate Cancer | Mark Moyad, MD, MPH & Mark Scholz, MD

|
What Should Your PSA Be While on Lupron? & PSA With No Cancer | Answering YouTube Comments #25

What Should Your PSA Be While on Lupron? & PSA With No Cancer | Answering YouTube Comments #25

|
How to Integrate PSMA PET Findings Into Treatment Algorithms

How to Integrate PSMA PET Findings Into Treatment Algorithms

|
PSA After Radiation | Ask a Prostate Expert, Mark Scholz, MD

PSA After Radiation | Ask a Prostate Expert, Mark Scholz, MD

|
PSMA-PET for patients with high-risk for de novo N1 disease

PSMA-PET for patients with high-risk for de novo N1 disease

|
The role of PSMA PET in recurrent prostate cancer

The role of PSMA PET in recurrent prostate cancer

|
PSMA PET Imaging at Time of Diagnosis

PSMA PET Imaging at Time of Diagnosis

|
PSMA PET/CT: detection rate and impact on clinical practice

PSMA PET/CT: detection rate and impact on clinical practice

|
Postponing Hormone Resistance and Perineural Invasion | Answering YouTube Comments #41 | Dr. Scholz

Postponing Hormone Resistance and Perineural Invasion | Answering YouTube Comments #41 | Dr. Scholz

|
PSMA PET vs conventional imaging

PSMA PET vs conventional imaging

|
Which 2nd Gen Anti-Androgen, Cancer in the Prostate Fossa After Removal? | Answering Comments #40

Which 2nd Gen Anti-Androgen, Cancer in the Prostate Fossa After Removal? | Answering Comments #40

|
Radiation Centers, Secondary Cancers, IMRT vs Brachytherapy | Ask a Prostate Expert, Mark Scholz, MD

Radiation Centers, Secondary Cancers, IMRT vs Brachytherapy | Ask a Prostate Expert, Mark Scholz, MD

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa